Frequently Asked Questions
The market is segmented based on , By Products and Services (Reagents and Consumables, Instruments and Accessories, Software and Services), Type (Nucleic Acid Multiplex Assays, Protein Multiplex Assays, Cell-Based Multiplex Assays), Technology (Protein Microarray, Polymerase Chain Reaction, Multiplex Real-Time Polymerise Chain Reaction, Flow Cytometry, Fluorescence Detection, Luminescence, Others), Application (Clinical Diagnostics, Research and Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutes, Others) - Industry Trends and Forecast to 2031.
.
The Global Multiplex Assays Market size was valued at USD 3.44 USD Billion in 2023.
The Global Multiplex Assays Market is projected to grow at a CAGR of 7.13% during the forecast period of 2024 to 2031.
The major players operating in the market include Luminex Corporation, Thermo Fisher Scientific , Illumina , Bio-Rad Laboratories , QIAGEN, Abcam plc, BD, Merck KGaA, Agilent Technologies , Meso Scale Diagnostics, Randox Laboratories, Quanterix, Bio-Techne Corporation, Olink, DiaSorin S.p.A., Seegene, Promega Corporation, Siemens, PerkinElmer , Shimadzu Corporation,.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Belgium, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands Switzerland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa..
